Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals, Inc. in the Healthcare sector is trading at $1.00 with a market capitalization of $36M. Wall Street consensus targets $3.60 (5 analysts), implying a +260.2% move over the next 12 months. The stock is currently 43% below its 52-week high of $1.74, remaining 10.8% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 30 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.